Healthcare Services Group Toekomstige groei
Future criteriumcontroles 0/6
De winst van Healthcare Services Group zal naar verwachting dalen met 16.7% per jaar, terwijl de jaarlijkse omzet naar verwachting zal groeien met 5.4% per jaar. De winst per aandeel zal naar verwachting dalen met 14.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 14.8% zijn.
Belangrijke informatie
-16.7%
Groei van de winst
-14.51%
Groei van de winst per aandeel
| Commercial Services winstgroei | 13.0% |
| Inkomstengroei | 5.4% |
| Toekomstig rendement op eigen vermogen | 14.76% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 28 Jul 2026 |
Recente toekomstige groei-updates
Recent updates
Seeking Alpha • Jul 29
Healthcare Services Group: Operational Improvements Support Further Upside
Summary Healthcare Services Group is regaining profitability momentum through operational efficiency and disciplined cost management. HCSG posted higher income, improved operating margins, and reaffirmed mid-single-digit income growth guidance for the year. New customer acquisition and expansion with existing clients remain the primary growth drivers for HCSG. Strong balance sheet, favorable valuation, and demographic tailwinds support maintaining a buy rating on HCSG. Read the full article on Seeking Alpha
Narratiefupdate • Jun 17
HCSG: Buybacks And Steady Execution Will Support Future Share Price Upside
Analysts have revised their price targets for Healthcare Services Group stock, with several firms raising targets by $2 and one firm lowering its target by $3. These changes reflect differing views on the company, while the underlying fair value and key model inputs remain essentially unchanged.Narratiefupdate • Jun 02
HCSG: Buybacks And Steady Execution Will Support Future Earnings Resilience
Analysts have raised their average price target on Healthcare Services Group by $2, reflecting updated views on valuation after several firms adjusted their expectations for the stock. Analyst Commentary Recent research updates show a mix of optimism and caution around Healthcare Services Group, centered on how the stock is priced against execution risks and growth expectations.Narratiefupdate • May 03
HCSG: Outsourced Services And Buybacks Will Drive Future Earnings Resilience
The analyst price target for Healthcare Services Group has been revised from $24 to $26.20 as analysts factor in modestly higher modeled revenue growth, a slightly lower profit margin, and updated P/E assumptions informed by recent target changes across firms such as RBC Capital, UBS, Benchmark, Baird, and BMO Capital. Analyst Commentary Recent Street research on Healthcare Services Group reflects a mix of constructive and cautious views, with several firms adjusting price targets and one initiating coverage with a neutral stance.Narratiefupdate • Apr 19
HCSG: Outsourced Services And Buybacks Will Support Future Earnings Resilience
The analyst price target for Healthcare Services Group has moved to $24.00, with analysts pointing to improving unit economics, supportive payor policies, resilient demand from skilled nursing facility clients, and limited perceived AI risk, while still identifying labor supply and valuation as key areas to watch. Analyst Commentary Recent research has focused on both the improving fundamentals at Healthcare Services Group and the risks that could affect execution and valuation from here.Narratiefupdate • Apr 03
HCSG: Outsourced Non Clinical Services And Buybacks Will Support Future Returns
Analysts have modestly raised their average price target on Healthcare Services Group to $24.00 per share, citing improving unit economics, stronger demand from skilled nursing facility clients, limited AI risk to the business model, and a more cautious stance on labor supply and current valuation following the recent rally. Analyst Commentary Bullish Takeaways Bullish analysts view improving unit economics as a key support for execution, suggesting the company may have more room to invest in service quality and client retention while still protecting margins.Narratiefupdate • Mar 19
HCSG: Outsourced Non Clinical Services And Buybacks Will Support Future Returns
Narrative Update on Healthcare Services Group The analyst price target for Healthcare Services Group has been refined to $24.00. This reflects updated views that balance improving unit economics, resilient demand from skilled nursing facilities, minimal AI risk to the business model, and ongoing caution around labor supply and current valuation.Narratiefupdate • Mar 05
HCSG: Outsourced Non Clinical Services And Buybacks Will Drive Future Upside
Analysts have trimmed their fair value estimate for Healthcare Services Group by $0.50 to $24.00. This reflects a slightly lower future P/E assumption, even as they highlight benefits from stronger end market demand, a stable labor backdrop, and potential upside from increasing outsourcing of non clinical services.Narratiefupdate • Feb 19
HCSG: Higher Future P/E Assumptions Will Support Stronger Upside Potential
The updated analyst work on Healthcare Services Group lifts the fair value estimate from $21.50 to $24.50, reflecting higher Street price targets and analyst expectations for a richer future P/E multiple, even as inputs such as revenue growth, profit margin, and discount rate are adjusted. Analyst Commentary Recent Street research shows several price target increases clustered around the same time, which lines up with the higher fair value estimate.Narratiefupdate • Feb 04
HCSG: Stable Assumptions At US$21.50 Fair Value Will Support Future Upside
Analysts have made only a marginal adjustment to their price target for Healthcare Services Group, holding fair value at about $21.50. Small tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions did not materially change their outlook.Narratiefupdate • Jan 21
HCSG: Higher UBS Price Setting Will Support A Stronger Future Upside
Analysts have raised their price target on Healthcare Services Group by $2 to $22, reflecting updated views that incorporate a steady fair value estimate along with slightly revised assumptions for discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent research commentary focuses on how the updated US$22 price target lines up with assumptions around fair value, execution, and earnings power rather than signaling a dramatic shift in the story.Narratiefupdate • Jan 06
HCSG: Buybacks And Education Acquisitions Will Support A Higher Future Price
Analysts recently lifted their price target on Healthcare Services Group to $22 from $20, citing updated views on the stock's valuation, even as key model inputs such as fair value, discount rate, revenue growth, profit margin, and future P/E assumptions remain effectively unchanged. Analyst Commentary Recent commentary around the updated US$22 price target focuses less on new financial assumptions and more on how the market is pricing Healthcare Services Group relative to those existing assumptions.Narratiefupdate • Dec 23
HCSG: Modest Price Increase And Buybacks Will Support Balanced Future Outlook
Analysts modestly raised their price target on Healthcare Services Group to $22 from $20, reflecting slightly improved long term growth and valuation assumptions, despite only marginal adjustments to revenue growth and profit margin forecasts. Analyst Commentary Analysts describe the modest price target increase as a reflection of greater confidence in the company’s ability to sustain mid single digit revenue growth while gradually improving operating efficiency.Narratiefupdate • Dec 09
HCSG: Higher Price Objective And Buybacks Will Support Bullish Outlook
Analysts have raised their price target on Healthcare Services Group by $2 to $22, citing continued confidence in the company's outlook and maintaining a positive rating on the shares. Analyst Commentary Bullish analysts highlight that the higher price target reflects growing confidence that Healthcare Services Group can sustain its recent operational improvements, supporting an upward re-rating of the shares.Narratiefupdate • Nov 25
HCSG: Share Buybacks Will Drive Upside As Education Acquisitions Accelerate
Healthcare Services Group’s fair value price target has been modestly lowered by analysts from $22.00 to $21.50. This change reflects slight downward adjustments to future growth and margin estimates.Narratiefupdate • Nov 07
HCSG: Share Buybacks And Education Acquisitions Will Drive Future Upside
Analysts have raised their price target for Healthcare Services Group from $21.33 to $22.00. They cited modest improvements in projected revenue growth and a slight increase in discount rates as key factors behind the update.Narratiefupdate • Oct 23
Stable Industry Trends And Aging Demographics Will Drive Sector Opportunities
Analysts have raised their price target for Healthcare Services Group from $18.00 to $21.33 per share. They cite stable industry fundamentals and improved growth momentum as key drivers behind the upward revision.Narratiefupdate • Sep 21
Aging US Demand Will Expand Long-Term Care Opportunities
Despite a slight downgrade in consensus revenue growth forecasts, a higher forward P/E multiple has driven the consensus Analyst Price Target for Healthcare Services Group up from $17.00 to $18.00. What's in the News Repurchased 566,997 shares for $7.6 million in the latest tranche, completing 2,690,108 shares for $30.67 million under the buyback program.Analyse-artikel • Sep 12
Estimating The Fair Value Of Healthcare Services Group, Inc. (NASDAQ:HCSG)
Key Insights The projected fair value for Healthcare Services Group is US$16.56 based on 2 Stage Free Cash Flow to...Analyse-artikel • Apr 30
Earnings Beat: Healthcare Services Group, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Shareholders will be ecstatic, with their stake up 49% over the past week following Healthcare Services Group, Inc. 's...Analyse-artikel • Apr 24
Healthcare Services Group, Inc. (NASDAQ:HCSG) Not Flying Under The Radar
With a price-to-earnings (or "P/E") ratio of 21.6x Healthcare Services Group, Inc. ( NASDAQ:HCSG ) may be sending...Seeking Alpha • Mar 26
Healthcare Services Group: Waiting For More Evidence Of Trend-Change
Summary Potential bottoming technical pattern forming on the technical chart. Investors becoming interested once more in Healthcare Services Group due to attractive valuation, buoyant cash-flow & encouraging macro-trends. High receivables amid high costs continue to bring risk concerning forward-looking return on capital. Read the full article on Seeking AlphaAnalyse-artikel • Nov 19
Healthcare Services Group (NASDAQ:HCSG) Has A Rock Solid Balance Sheet
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyse-artikel • Oct 08
Healthcare Services Group, Inc.'s (NASDAQ:HCSG) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 22.7x Healthcare Services Group, Inc. ( NASDAQ:HCSG ) may be sending...
Nieuw narratief • Sep 24
Recovering Cash Flow And Expanding Services Set To Propel Growth Amid Challenges
Improvement in cash flow anticipated from resolving delayed cash collections, with increased demand for dining and nutrition services suggesting revenue growth.Analyse-artikel • Sep 17
Healthcare Services Group (NASDAQ:HCSG) Could Be Struggling To Allocate Capital
When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...Analyse-artikel • Jul 25
Is Healthcare Services Group (NASDAQ:HCSG) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyse-artikel • May 22
Here's Why It's Unlikely That Healthcare Services Group, Inc.'s (NASDAQ:HCSG) CEO Will See A Pay Rise This Year
Key Insights Healthcare Services Group's Annual General Meeting to take place on 28th of May Salary of US$1.01m is part...Analyse-artikel • Feb 06
Healthcare Services Group, Inc.'s (NASDAQ:HCSG) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 20.8x Healthcare Services Group, Inc. ( NASDAQ:HCSG ) may be sending...Seeking Alpha • Jan 30
Healthcare Services Group: Maintaining Our Bearish Stance
Summary Healthcare Services Group stock has dropped almost 35% since last year, underperforming the market. HCSG's return on capital is significantly lower than its 5-year average and the sector average. Ongoing uncertainty surrounding the nursing home staffing rule and bearish EPS revisions contribute to the 'Sell' rating on HCSG. Read the full article on Seeking AlphaAnalyse-artikel • Nov 16
Calculating The Intrinsic Value Of Healthcare Services Group, Inc. (NASDAQ:HCSG)
Key Insights The projected fair value for Healthcare Services Group is US$11.37 based on Dividend Discount Model...Analyse-artikel • Oct 26
Healthcare Services Group (NASDAQ:HCSG) May Have Issues Allocating Its Capital
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...Analyse-artikel • Jul 31
These 4 Measures Indicate That Healthcare Services Group (NASDAQ:HCSG) Is Using Debt Safely
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyse-artikel • Jun 09
Returns On Capital Signal Difficult Times Ahead For Healthcare Services Group (NASDAQ:HCSG)
If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? A business...Analyse-artikel • Apr 11
Healthcare Services Group, Inc.'s (NASDAQ:HCSG) Intrinsic Value Is Potentially 95% Above Its Share Price
Key Insights The projected fair value for Healthcare Services Group is US$28.01 based on 2 Stage Free Cash Flow to...Analyse-artikel • Mar 24
Is Healthcare Services Group (NASDAQ:HCSG) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyse-artikel • Mar 03
Healthcare Services Group (NASDAQ:HCSG) Will Be Looking To Turn Around Its Returns
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...Analyse-artikel • Dec 21
Is Healthcare Services Group (NASDAQ:HCSG) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyse-artikel • Nov 30
Healthcare Services Group (NASDAQ:HCSG) May Have Issues Allocating Its Capital
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2028 | 2,116 | 93 | N/A | N/A | 1 |
| 12/31/2027 | 2,034 | 78 | 96 | 98 | 6 |
| 12/31/2026 | 1,921 | 78 | 100 | 105 | 6 |
| 6/30/2026 | 1,865 | 123 | 149 | 154 | N/A |
| 3/31/2026 | 1,852 | 68 | 156 | 161 | N/A |
| 12/31/2025 | 1,837 | 59 | 139 | 145 | N/A |
| 9/30/2025 | 1,808 | 40 | 158 | 164 | N/A |
| 6/30/2025 | 1,772 | 11 | 91 | 97 | N/A |
| 3/31/2025 | 1,740 | 41 | 78 | 84 | N/A |
| 12/31/2024 | 1,716 | 39 | 24 | 31 | N/A |
| 9/30/2024 | 1,702 | 51 | 38 | 44 | N/A |
| 6/30/2024 | 1,685 | 32 | 36 | 43 | N/A |
| 3/31/2024 | 1,678 | 42 | 27 | 34 | N/A |
| 12/31/2023 | 1,671 | 38 | 38 | 43 | N/A |
| 9/30/2023 | 1,672 | 31 | 12 | 17 | N/A |
| 6/30/2023 | 1,675 | 36 | -1 | 4 | N/A |
| 3/31/2023 | 1,681 | 35 | 1 | 6 | N/A |
| 12/31/2022 | 1,690 | 34 | -13 | -8 | N/A |
| 9/30/2022 | 1,687 | 21 | -5 | 0 | N/A |
| 6/30/2022 | 1,688 | 30 | -19 | -13 | N/A |
| 3/31/2022 | 1,661 | 33 | -3 | 3 | N/A |
| 12/31/2021 | 1,642 | 49 | 31 | 37 | N/A |
| 9/30/2021 | 1,645 | 72 | 76 | 81 | N/A |
| 6/30/2021 | 1,665 | 90 | 149 | 154 | N/A |
| 3/31/2021 | 1,719 | 103 | 204 | 208 | N/A |
| 12/31/2020 | 1,760 | 99 | 213 | 217 | N/A |
| 9/30/2020 | 1,784 | 90 | 151 | 155 | N/A |
| 6/30/2020 | 1,804 | 81 | 162 | 166 | N/A |
| 3/31/2020 | 1,814 | 76 | N/A | 89 | N/A |
| 12/31/2019 | 1,841 | 65 | N/A | 94 | N/A |
| 9/30/2019 | 1,889 | 77 | N/A | 86 | N/A |
| 6/30/2019 | 1,939 | 85 | N/A | 73 | N/A |
| 3/31/2019 | 1,978 | 93 | N/A | 74 | N/A |
| 12/31/2018 | 2,003 | 84 | N/A | 80 | N/A |
| 9/30/2018 | 2,007 | 72 | N/A | 79 | N/A |
| 6/30/2018 | 1,993 | 70 | N/A | 42 | N/A |
| 3/31/2018 | 1,962 | 66 | N/A | -3 | N/A |
| 12/31/2017 | 1,861 | 88 | N/A | 8 | N/A |
| 9/30/2017 | 1,765 | 88 | N/A | 7 | N/A |
| 6/30/2017 | 1,667 | 85 | N/A | 15 | N/A |
| 3/31/2017 | 1,582 | 81 | N/A | 66 | N/A |
| 12/31/2016 | 1,563 | 77 | N/A | 41 | N/A |
| 9/30/2016 | 1,530 | 66 | N/A | 49 | N/A |
| 6/30/2016 | 1,498 | 64 | N/A | 50 | N/A |
| 3/31/2016 | 1,466 | 61 | N/A | 79 | N/A |
| 12/31/2015 | 1,437 | 58 | N/A | 63 | N/A |
| 9/30/2015 | 1,412 | 64 | N/A | 87 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De winst van HCSG zal naar verwachting de komende 3 jaar dalen ( -16.7% per jaar).
Winst versus markt: De winst van HCSG zal naar verwachting de komende 3 jaar dalen ( -16.7% per jaar).
Hoge groeiwinsten: De winst van HCSG zal naar verwachting de komende 3 jaar dalen.
Omzet versus markt: De omzet van HCSG ( 5.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 12.4% per jaar).
Hoge groei-inkomsten: De omzet van HCSG ( 5.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen HCSG zal naar verwachting over 3 jaar laag zijn ( 14.8 %).
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/07/30 16:57 |
| Aandelenkoers aan het einde van de dag | 2026/07/30 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Healthcare Services Group, Inc. wordt gevolgd door 15 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Andrew Wittmann | Baird |
| James Terwilliger | Benchmark Company |
| William Sutherland | Benchmark Company |